[Effects of endostatin and doxycycline on microcirculation patterns in melanoma and their relevant molecular

Bao-cun Sun1, Shi-wu Zhang, Li-sha Qi

  • 1Department of Pathology, Tumor Hospital, Tianjin Medical University, China. baocunsun@eyou.com

Abstract

Insights

Endostatin and doxycycline combination therapy significantly inhibits melanoma growth by reducing matrix metalloproteinase (MMP) expression and altering microcirculation patterns, including mosaic vessels and vasculogenic mimicry.

Area of Science:

  • Oncology
  • Vascular Biology
  • Pharmacology

Background:

  • Melanoma exhibits complex microcirculation patterns crucial for tumor growth.
  • Matrix metalloproteinases (MMPs) play a significant role in melanoma progression and angiogenesis.

Purpose of the Study:

  • To investigate the therapeutic effects of endostatin and doxycycline on melanoma microcirculation.
  • To elucidate the molecular mechanisms underlying these effects, focusing on MMP expression and activity.

Main Methods:

  • A mouse B16 melanoma model was established.
  • Mice were treated with endostatin, doxycycline, or a combination.
  • Tumor growth, microcirculation patterns (endothelium-dependent vessels, mosaic vessels, vasculogenic mimicry), MMP/TIMP expression, and MMP activity were assessed.

Main Results:

  • Combined endostatin and doxycycline significantly reduced tumor growth compared to controls.
  • Treatment decreased the expression and activity of MMP-2 and MMP-9.
  • Formation of mosaic vessels and vasculogenic mimicry was significantly reduced in treated groups.

Conclusions:

  • Combined endostatin and doxycycline therapy effectively inhibits melanoma growth.
  • The mechanism involves the downregulation of MMPs, impacting melanoma microcirculation and angiogenesis.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...